Does Paramount's acquisition of Warner Bros. Discovery ultimately close?
Will Paramount Skydance's approximately $110 billion all-cash acquisition of Warner Bros. Discovery ultimately close, rather than being permanently blocked or abandoned following the states' antitrust challenge?
Leans toward eventual closing — DOJ already cleared the deal federally and the arb spread implies the market still sees completion as more likely than not, but a dozen state AGs pursuing a live Clayton Act trial next March is a real, uncompleted legal test
The case for closing: DOJ's own eight-month federal review found no competition problem, both companies' shareholders already approved the deal, Paramount has shown it's willing to pay an escalating daily fee rather than walk away, and merger-arb pricing has historically treated state-only antitrust suits (as opposed to a DOJ challenge) as a lower-probability path to actually blocking a deal. The case against: twelve states plus California specifically allege reduced competition in theatrical distribution and cable-channel licensing — concrete, arguable harms a federal judge could credit — the states and the Writers Guild of America both have party status in the case, and the trial itself hasn't happened yet, so this is a real unresolved legal fight rather than a formality.
No fixed date · A 12-state Clayton Act antitrust trial is scheduled for March 2-19, 2027 in the Northern District of California; Paramount has agreed not to close before five days after a trial ruling or June 1, 2027 (whichever is earlier), but no fixed date exists for the deal's ultimate outcome
Paramount Skydance's cash offer for Warner Bros. Discovery cleared DOJ antitrust review in June 2026 after an eight-month investigation, and both companies' shareholders approved the roughly $110B deal. In July 2026, twelve Democratic-led states plus California sued in the Northern District of California to block it under the Clayton Act, arguing it would substantially lessen competition in wide-release theatrical film distribution and basic-cable-channel licensing. Rather than litigate a preliminary-injunction fight, Paramount agreed to delay closing until five days after a trial verdict or June 1, 2027, whichever comes first; the court has since set the trial itself for March 2-19, 2027. A 'ticking fee' of roughly $0.0028/share/day (close to $7M/day in aggregate) has been accruing since Sept 30, 2026 and is added to the $31/share cash consideration the longer the deal takes to close. WBD shares have traded in the high-$20s this fall (around $28 as of early September) against the $31 offer — a high-single-digit-to-low-teens percent gross spread that reflects real but not extreme perceived deal risk given the trial is still roughly five months away.
The deal either closes — at some point after the states' Clayton Act trial resolves in Paramount's favor or the claims are otherwise cleared — or it is permanently blocked or abandoned, a discrete corporate-control outcome with no partial middle state.
Researched Oct 14, 2026 · tracked since Oct 14, 2026
Build a position
You agree with the market.
Nothing here has positive expected value — the price already reflects this view. Move the slider to where you think the odds actually are.
Take a side
The merger ultimately closesthis is “yes”
DOJ's own eight-month federal antitrust review already cleared the deal, both companies' shareholders approved it, Paramount has shown its willingness to keep paying an escalating daily fee rather than walk away, and state-only antitrust challenges have a weaker historical track record of permanently blocking cleared mega-mergers than DOJ-led suits.
Worth knowing: The arbitrage spread has stayed in the high-single-to-low-teens percent range for months rather than collapsing toward zero — the market is pricing real, uncompleted trial risk, not treating this as a done deal.
The merger is blocked or abandoned
Twelve state attorneys general plus the Writers Guild of America are pursuing a live Clayton Act trial next March with specific, arguable theories of harm in theatrical distribution and cable-channel licensing — a real test that hasn't happened yet, not a formality DOJ clearance already resolved.
Worth knowing: A loss at trial wouldn't necessarily end the deal outright — Paramount could still appeal or renegotiate terms, so don't assume an adverse trial ruling is automatically the final word either.
5 sources, leaning both ways
- noMissouri Independent — Oregon, 11 other states sue to block Paramount-Warner Bros. mergerReports the 12-state Clayton Act suit's core theory: the merger would substantially lessen competition in wide-release and top-grossing theatrical film distribution and in licensing basic cable channels to distributors.
- mixedThe Hollywood Reporter — Paramount, Warner Bros. Merger Until After Antitrust TrialConfirms the trial is set for March 2-19, 2027 in the Northern District of California, with the states and WGA as parties, and that Paramount agreed not to close before the trial resolves or June 1, 2027.
- mixedTheWrap — Paramount Agrees to Push Warner Bros. Merger as Far Back as Summer 2027Reports Paramount withdrew its request for an Aug 3, 2026 preliminary-injunction hearing in exchange for the states' agreement not to seek an injunction before trial, and describes the ticking-fee mechanism added to the deal consideration.
- yesTradingNews — WBD ($25.61) Carries a $5.39 Spread and a $7B Break Fee as the Trial Schedule Filing Lands July 31Details the arbitrage spread, the $7B break fee, and the ticking-fee mechanics as of late July — a persistent but not blown-out spread consistent with the market still pricing completion as the more likely outcome over a long horizon.
- yesDiarioBitcoin — Kalshi y Polymarket ven 22% de probabilidad de que fracase la fusión Paramount-Warner BrosReports Kalshi/Polymarket pricing around a 22% chance the deal fails to close before July 2027 as of late July 2026 (implying roughly 78% for eventual closing), while noting the lawsuit cut the deal's priced odds down from above 80% beforehand.